This Monday, there was a pivotal ruling from the U.S., which carries significant implications for the pharmaceutical industry and healthcare costs. 🔍 Case Summary: The court rejected a legal ...
A federal judge has dismissed legal challenges to the Medicare negotiation program brought by Bristol Myers Squibb and Johnson & Johnson, ruling that their claims of unconstitutionality are unfounded.
Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar ...
- A US district court judge has found Bristol-Myers Squibb's patent on the use of Buspar (buspirone), used in the treatment of ...
The United States(US) Patent Office dominates the patent filings and grants with nearly 24% filings and 23% grants. The United ...
At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities ...
Johnson & Johnson saw the highest growth of 114% in patent filings and 122% in grants in January in Q1 2024. Compared to Q4 2023 ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Bristol Myers Squibb wants patients living with schizophrenia to experience life to the fullest extent possible. That’s why the ...
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
Xtrackers S&P 500 Swap UCITS ETF - 1C USD ACC 30% iShares Core S&P 500 UCITS ETF - USD ACC 30% iShares Core S&P 500 UCITS ETF USD - DIS 30% ...